Showing results (251-260 of 753) with videos related to
Sort By:
Pageof 76
IEEE Transactions on Bio-Medical Engineering|May 30, 2024
Non-Invasive Blood-Brain Barrier Disruption Using Acoustic Holography With a Clinical Focused Ultrasound SystemNathan McDannold, Yongzhi Zhang, Stecia-Marie Fletcher, et al.Journal of Neuro-Oncology|March 3, 2007
Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomideMichelle L Monje, Naren R Ramakrishna, Geoffrey Young, et al.Neuro-Oncology Advances|February 5, 2024
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forwardEmily J Smith, Anant Naik, Mahima Goel, et al.Neuro-Oncology|September 2, 2008
Colon perforation during antiangiogenic therapy for malignant gliomaAndrew D Norden, Jan Drappatz, Abigail Slate Ciampa, et al.The Journal of Molecular Diagnostics : JMD|July 23, 2013
The role of MGMT testing in clinical practice: a report of the association for molecular pathologyMilena Cankovic, Marina N Nikiforova, Matija Snuderl, et al.Neuro-Oncology|March 11, 2009
Racial differences in primary central nervous system lymphoma incidence and survival ratesJose S Pulido, Robert A Vierkant, Janet E Olson, et al.Cell Cycle (Georgetown, Tex.)|March 2, 2010
microRNA-34a is tumor suppressive in brain tumors and glioma stem cellsFadila Guessous, Ying Zhang, Alex Kofman, et al.Anti-Cancer Agents in Medicinal Chemistry|December 18, 2009
An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growthFadila Guessous, Ying Zhang, Charles diPierro, et al.Critical Care Medicine|July 9, 2005
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factorsDeborah Cook, Mark Crowther, Maureen Meade, et al.Journal of Neuro-Oncology|July 21, 2014
Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade gliomaJasmin Jo, Brian Williams, Mark Smolkin, et al.Pageof 76